Autonomic nervous system dysfunction and adrenoceptor regulation in Parkinson's disease. Clinical and pharmacological consequences.
Montastruc
J L
JL
Laboratoire de Pharmacologie Médicale et Clinique, INSERM U317, Toulouse, France.
Senard
J M
JM
Rascol
O
O
Rascol
A
A
D000978:Antiparkinson Agents / Q000627:therapeutic use; D001342:Autonomic Nervous System Diseases / Q000188:drug therapy / Q000503:physiopathology*; D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy / Q000503:physiopathology*; D011941:Receptors, Adrenergic / Q000187:drug effects / Q000502:physiology*
D000978:Antiparkinson Agents; D011941:Receptors, Adrenergic